Healthcare & Life Sciences
TC Biopharm
United Kingdom
alive
About
TC Biopharm develops an off-the-shelf allogeneic gamma delta T cell therapy platform designed to create scalable cell-based immunotherapies.
Explore TC Biopharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.